Literature DB >> 20635309

High-throughput screening of natural products for cancer therapy.

Alan L Harvey1, Ian A Cree.   

Abstract

Natural products have been the biggest single source of anticancer drugs and there are continued efforts to explore the chemical diversity provided by nature in order to find new lead compounds. Bioassay test methods have developed into high throughput screening assays using both cell-based and molecular approaches. The various ways to detect effects on cell viability and cell proliferation are summarised and examples are given of developments using three-dimensional cultures and cancer stem cells. Cell-based reporter assays have also been created in order to look more directly for effects on specific physiological pathways. The molecular assays include those directed at microtubules and related proteins and at many different protein kinases. Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635309     DOI: 10.1055/s-0030-1250162

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  17 in total

1.  Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.

Authors:  Sandra Craig; Lei Gao; Irene Lee; Thomas Gray; Anthony J Berdis
Journal:  J Med Chem       Date:  2012-02-15       Impact factor: 7.446

2.  Has discovery-based cancer research been a bust?

Authors:  R J Epstein
Journal:  Clin Transl Oncol       Date:  2013-09-04       Impact factor: 3.405

3.  Targeting the target of rapamycin (TOR): looking to mother nature.

Authors:  Eric K Rowinsky
Journal:  Target Oncol       Date:  2011-04-27       Impact factor: 4.493

4.  Liquid gradient in two-dimensional matrix for high throughput screening.

Authors:  Shan-Wen Hu; Bi-Yi Xu; Jing-Juan Xu; Hong-Yuan Chen
Journal:  Biomicrofluidics       Date:  2013-12-10       Impact factor: 2.800

5.  Natural product libraries to accelerate the high-throughput discovery of therapeutic leads.

Authors:  Tyler A Johnson; Johann Sohn; Wayne D Inman; Samarkand A Estee; Steven T Loveridge; Helene C Vervoort; Karen Tenney; Junke Liu; Kenny Kean-Hooi Ang; Joseline Ratnam; Walter M Bray; Nadine C Gassner; Young Y Shen; R Scott Lokey; James H McKerrow; Kyria Boundy-Mills; Arif Nukanto; Atit Kanti; Heddy Julistiono; Leonardus B S Kardono; Leonard F Bjeldanes; Phillip Crews
Journal:  J Nat Prod       Date:  2011-11-30       Impact factor: 4.050

6.  Network-based drug discovery by integrating systems biology and computational technologies.

Authors:  Elaine L Leung; Zhi-Wei Cao; Zhi-Hong Jiang; Hua Zhou; Liang Liu
Journal:  Brief Bioinform       Date:  2012-08-09       Impact factor: 11.622

7.  Efficient screening of marine extracts for protease inhibitors by combining FRET based activity assays and surface plasmon resonance spectroscopy based binding assays.

Authors:  Tony Christopeit; Kersti Øverbø; U Helena Danielson; Inge W Nilsen
Journal:  Mar Drugs       Date:  2013-10-30       Impact factor: 5.118

8.  A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.

Authors:  Chih-Yang Huang; Da-Tong Ju; Chih-Fen Chang; P Muralidhar Reddy; Bharath Kumar Velmurugan
Journal:  Biomedicine (Taipei)       Date:  2017-11-13

9.  In silico characterization of cell-cell interactions using a cellular automata model of cell culture.

Authors:  Takanori Kihara; Kosuke Kashitani; Jun Miyake
Journal:  BMC Res Notes       Date:  2017-07-14

10.  What does it take to synergistically combine sub-potent natural products into drug-level potent combinations?

Authors:  Chu Qin; Kai Leng Tan; Cun Long Zhang; Chun Yan Tan; Yu Zong Chen; Yu Yang Jiang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.